Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katherine Thorley"'
Autor:
Katie A. Karkowski, Samer Ibrahim, Katherine Thorley, Catherine J. Rodriguez, Lixi Kong, David L. Crosby, Frederick Lansigan
Publikováno v:
JCO oncology practice. 18(9)
PURPOSE: Reduction of chemotherapy start times (CST) and length of stay (LOS) for elective chemotherapy admissions is a priority. The aim of this project was to improve efficiency of patient care while simultaneously increasing revenue by reducing LO
Autor:
Evelyn Schlosser, Melissa C. Davis, Lanelle Jalowiec, Linda P. Mason, Camilo E. Fadul, David Nalepinski, Katherine Thorley, Jennifer Hong, Natalie B. Riblet, Nancy L. Kennedy, Lara K Ronan, Tobi J. Cooney, Sabrina Richie, Jennifer Snide
BACKGROUND: Patients with glioma are at high risk for tumor and treatment related complications. Few guidelines exist to direct the management of these supportive care needs. Our prior work suggests that a standardized clinical care pathway can impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af223d78ef410c4db821cafcc328ea03
https://europepmc.org/articles/PMC4638849/
https://europepmc.org/articles/PMC4638849/
Autor:
Jennifer Hong, Katherine Thorley, Lanelle Jalowiec, Natalie B.V. Riblet, Nancy L. Kennedy, Melissa C. Davis, David Nalepinski, Evelyn Schlosser, Linda P. Mason, Tobi J. Cooney, Camilo E. Fadul, Lara Kunschner Ronan, Jennifer Snide, Sabrina Richie
Publikováno v:
Neuro-oncology practice. 3(3)
BackgroundPatients with glioma are at increased risk for tumor-related and treatment-related complications. Few guidelines exist to manage complications through supportive care. Our prior work suggests that a clinical care pathway can improve the car
Autor:
Sabrina Powers, Linda P. Mason, Katherine Thorley, Lara Kunschner Ronan, Tobi J. Cooney, Jennifer Snide, Nancy L. Kennedy, Evelyn Schlosser, Natalie B.V. Riblet, Lanelle Jalowiec, Camilo E. Fadul, David Nalepinski
Publikováno v:
Journal of Clinical Oncology. 32:217-217
217 Background: Gliomas account for nearly 80% of primary malignant brain tumors and are associated with poor survival. Developing clinical care pathways to ensure that patients receive coordinated, comprehensive and timely care may result in improve